Technology | June 16, 2015

Apple Introduces ResearchKit Mobile Platform

Open software framework gives medical researchers the tools to improve collection of medical research data

Apple, ResearchKit, open software research, medical research apps

June 16, 2015 - In March, Apple announced the launch of ResearchKit, an open source software framework designed for medical and health research. The platform is designed to help doctors and scientists gather data more frequently and more accurately from participants using iPhone apps. World-class research institutions have already developed apps with ResearchKit for studies on asthma, breast cancer, cardiovascular disease, diabetes and Parkinson's disease. Users decide if they want to participate in a study and how their data is shared.

ResearchKit turns iPhone into a powerful tool for medical research. When granted permission by the user, apps can access data from the Health app such as weight, blood pressure, glucose levels and asthma inhaler use, which are measured by third-party devices and apps. HealthKit is a software framework Apple introduced with iOS 8 to provide developers the ability for health and fitness apps to communicate with each other. ResearchKit can also request access to the accelerometer, microphone, gyroscope and GPS sensors in iPhone to gain insight into a patient's gait, motor impairment, fitness, speech and memory.

ResearchKit also makes it easier to recruit participants for large-scale studies, accessing a broad cross-section of the population - not just those within driving distance of an institution. Study participants can complete tasks or submit surveys right from the app, so researchers spend less time on paperwork and more time analyzing data. ResearchKit also enables researchers to present an interactive informed consent process. Users choose which studies to participate in and the data they want to provide in each study.

"We're excited to use these new ResearchKit tools from Apple to expand participant recruitment and quickly gather even more data through the simple use of an iPhone app. The data it will provide takes us one step closer to developing more personalized care," said Patricia Ganz, M.D., professor at the UCLA Fielding School of Public Health and director of cancer prevention & control research at UCLA's Jonsson Comprehensive Cancer Center. "Access to more diverse patient-reported health data will help us learn more about long-term aftereffects of cancer treatments and provide us with a better understanding of the breast cancer patient experience."

"When it comes to researching how we can better diagnose and prevent disease, numbers are everything. By using Apple's new ResearchKit framework, we're able to extend participation beyond our local community and capture significantly more data to help us understand how asthma works," said Eric Schadt, Ph.D., the Jean C. and James W. Crystal Professor of Genomics at the Icahn School of Medicine at Mount Sinai, and founding director of the Icahn Institute for Genomics and Multiscale Biology. "Using iPhone's advanced sensors, we're able to better model an asthma patient's condition to enable us to deliver a more personalized, more precise treatment."

Developed by the Icahn School of Medicine at Mount Sinai and LifeMap Solutions, the Asthma Health app is designed to facilitate asthma patient education and self-monitoring, promote positive behavioral changes and reinforce adherence to treatment plans according to current asthma guidelines. The study tracks symptom patterns in an individual and potential triggers for these exacerbations so that researchers can learn new ways to personalize asthma treatment.

Other health apps already designed include:

  • The Share the Journey app, developed by the Dana-Farber Cancer Institute, Penn Medicine, Sage Bionetworks and UCLA's Jonsson Comprehensive Cancer Center, is a research study that aims to understand why some breast cancer survivors recover faster than others, why their symptoms vary over time and what can be done to improve symptoms. Share the Journey uses surveys and sensor data on iPhone to collect and track fatigue, mood and cognitive changes, sleep disturbances and reduction in exercise.
  • Developed by Stanford Medicine, the MyHeart Counts app measures activity and uses risk factor and survey information to help researchers more accurately evaluate how a participant's activity and lifestyle relate to cardiovascular health. By studying these relationships on a broad scale, researchers will be able to understand better how to keep hearts healthier.
  • Massachusetts General Hospital developed the GlucoSuccess app to understand how various aspects of a person's life - diet, physical activity and medications - affect blood glucose levels. The app can also help participants identify how their food choices and activity relate to their best glucose levels, enabling them to clearly see correlations and take more active roles in their own well-being.
  • Developed by Sage Bionetworks and the University of Rochester, the Parkinson mPower app helps people living with Parkinson's disease track their symptoms by recording activities using sensors in iPhone. These activities include a memory game, finger tapping, speaking and walking. Activity and survey data from the phone are combined with data from many other participants to fuel Parkinson's research at a scale never before possible, making it the world's largest and most comprehensive study of this disease.

 

ResearchKit was released as an open source framework in April, providing researchers with the ability to contribute to specific activity modules in the framework, like memory or gait testing, and share them with the global research community to further advance what we know about disease.

ResearchKit apps are available on the App Store.

 

For more information: www.apple.com/researchkit

Related Content

Novel Technique May Significantly Reduce Breast Biopsies
News | Breast Biopsy Systems | January 17, 2019
A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce...
Digital Mammography Increases Breast Cancer Detection
News | Mammography | January 16, 2019
The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United...
Artificial Intelligence Used in Clinical Practice to Measure Breast Density
News | Artificial Intelligence | January 15, 2019
An artificial intelligence (AI) algorithm measures breast density at the level of an experienced mammographer,...
Machine Learning Uncovers New Insights Into Human Brain Through fMRI
News | Neuro Imaging | January 11, 2019
An interdisciplinary research team led by scientists from the National University of Singapore (NUS) has successfully...
Mobile App Data Collection Shows Promise for Population Health Surveys
News | Population Health | January 10, 2019
Mobile app data collection can bring access to more potential clinical study participants, reduce clinical study...
Hypertension With Progressive Cerebral Small Vessel Disease Increases Cognitive Impairment Risk
News | Magnetic Resonance Imaging (MRI) | January 08, 2019
Patients with high blood pressure and progression of periventricular white matter hyperintensities showed signs of...
Artificial Intelligence Pinpoints Nine Different Abnormalities in Head Scans

A brain scan (left) showing an intraparenchymal hemorrhage in left frontal region and a scan (right) of a subarachnoid hemorrhage in the left parietal region. Both conditions were accurately detected by the Qure.ai tool. Image courtesy of Nature Medicine.

News | Artificial Intelligence | January 07, 2019
The rise in the use of computed tomography (CT) scans in U.S. emergency rooms has been a well-documented trend1 in...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
Breast Cancer Patients Have Less Heart Damage With Heart Drug and Trastuzumab
News | Cardio-oncology | January 03, 2019
Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage, according to a...